How are patients with active cancer and venous thromboembolism (VTE) treated in Germany? Answers from GECAT (German Evaluation of Cancer Associated Thrombosis)

被引：0
|
作者：
Sinn, M. [1 ,2 ]
Pollich, C. [3 ]
Riess, H. [1 ]
Bischoff, S. [1 ]
Habbel, P. [1 ]
Scholz, C. W. [4 ]
Spaeth-Schwalbe, E. [5 ]
de Wit, M. [6 ]
Juehling, A. [7 ]
Wolter, E. [1 ]
Wislocka, L. [1 ]
Klamroth, R. [3 ]
机构：
[1] Charite Univ Med Berlin, Hematol Oncol & Tumorimmunol, Berlin, Germany
[2] Univ Klinikum Hamburg Eppendorf, Ctr Oncol, Hamburg, Germany
[3] Vivantes Hosp Friedrichshain, Dept Internal Med Vasc Med & Haemostaseol, Berlin, Germany
[4] Vivantes, Hematol & Med Oncol, Berlin, Germany
[5] Vivantes Klinikum Spandau, Berlin, Germany
[6] Vivantes Klinikum Neukolln, Berlin, Germany
[7] Uniklinikum Koln, Cologne, Germany
来源：
THROMBOSIS RESEARCH | 2021年 / 200卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-37
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [1] GECAT - German Evaluation of Cancer Associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism (VTE) in Berlin
    Sinn, Marianne
    Pollich, Christiane
    Riess, Hanno
    Bischoff, Sven
    Habbel, Piet
    Scholz, Christian W.
    Spaeth-Schwalbe, Ernst
    de Wit, Maike
    Juehling, Anja
    Wolter, Eike
    Wislocka, Lilianna
    Klamroth
    BLOOD, 2019, 134
  • [2] Anticoagulation practice for cancer associated thrombosis (CAT) in Germany - Results from the German Evaluation of CAT (GECAT) registry
    Riess, H.
    Sinn, M.
    Pollich, C.
    Klamroth, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 49 - 49
  • [3] VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH PANCREATIC CANCER
    Kim, K. H.
    Yoon, S. Y.
    Yoon, J.
    Kim, H. J.
    Kim, S. H.
    Kim, H. J.
    Lee, S. C.
    Bae, S. B.
    Kim, C. K.
    Lee, N.
    Park, S. K.
    Won, J. H.
    Hong, D. S.
    Park, H. S.
    HAEMATOLOGICA, 2014, 99 : 780 - 781
  • [4] Venous Thromboembolism (VTE) In Patients With Pancreatic Cancer
    Kim, Kyoung Ha
    Yoon, Seug Yun
    Yoon, Jina
    Kim, Han Jo
    Kim, Se Hyung
    Kim, Hyun Jung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan-Kyu
    Lee, Namsu
    Park, Sung Kyu
    Won, Jong-Ho
    Hong, Dae Sik
    Park, Hee Sook
    BLOOD, 2013, 122 (21)
  • [5] Apixaban, Dalteparin, in Active Cancer Associated Venous Thromboembolism, the ADAM VTE Trial
    McBane, Robert D.
    Wysokinski, Waldemar E.
    Le-Rademacher, Jennifer
    Ashrani, Aneel A.
    Tafur, Alfonso J.
    Gundabolu, Krishna
    Perez-Botero, Juliana
    Perepu, Usha
    Anderson, Daniel M.
    Kuzma, Charles
    Ferre, Roberto Leon
    Henkin, Stanislav
    Lenz, Charles
    Loprinzi, Charles
    BLOOD, 2018, 132
  • [6] VTE Recurrence and Safety of Anticoagulants Among Patients with Cancer Treated for Venous Thromboembolism
    Khorana, Alok A.
    McCrae, Keith
    Milentijevic, Dejan
    McCormick, Nora
    Laliberte, Francois
    Crivera, Concetta
    Lefebvre, Patrick
    Lejeune, Dominique
    Rozjabek, Heather
    Schein, Jeff
    Streiff, Michael B.
    BLOOD, 2017, 130
  • [7] Venous thromboembolism (VTE) in patients with lung cancer (LC)
    Campayo, M.
    Font, C.
    Farrus, B.
    Reverter, J. C.
    Tassies, D.
    Reguart, N.
    Vinolas, N.
    Gascon, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism
    Hannevik, Trine-Lise
    Brekke, Jorunn
    Enden, Tone
    Froen, Hege
    Garresori, Herish
    Jacobsen, Eva Marie
    Paulsen, Petter Quist
    Porojnicu, Alina Carmen
    Ree, Anne Hansen
    Torfoss, Dag
    Velle, Elin Osvik
    Wik, Hilde Skuterud
    Ghanima, Waleed
    Sandset, Per Morten
    Dahm, Anders Erik Astrup
    THROMBOSIS RESEARCH, 2020, 196 : 238 - 244
  • [9] Treatment modalities in cancer-associated venous thromboembolism (VTE)
    Soto Alsar, Javier
    Ortiz de la Tabla, Ana Gutierrez
    Ortega Moran, Laura
    Munoz Martin, Andres J.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022, 35 (01)
  • [10] VTE-Related Healthcare Resource Utilization and Costs Associated with Venous Thromboembolism in Cancer Patients Treated with Anticoagulants
    Streiff, Michael
    Milentijevic, Dejan
    McCrae, Keith R.
    Fortier, Jonathan
    Laliberte, Francois
    Lefebvre, Patrick
    Schein, Jeff
    Khorana, Alok A.
    BLOOD, 2016, 128 (22)
12345